- Home
- LUCD vs ALPX Comparison
LUCD vs ALPX Comparison
Compare LUCD & ALPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.02
Company Overview
Basic Information| Metric | LUCD | ALPX |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.4M | 146.3M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LUCD | ALPX |
|---|---|---|
| Price | $1.02 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.13 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 58.7K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $115.58 | N/A |
| Revenue Next Year | $130.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.86 | $9.85 |
| 52 Week High | $1.63 | $9.90 |
Technical Indicators
Market Signals| Indicator | LUCD | ALPX |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 60.16 |
| Support Level | $0.88 | $9.85 |
| Resistance Level | $1.10 | N/A |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 72.65 | 71.18 |
Price Performance
Historical Comparison LUCD
ALPX
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About ALPX Alpex Acquisition Corporation Class A Ordinary Shares
Alpex Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.